世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000041666

閉経後骨粗鬆症の世界市場洞察(2025年)- 2030年までの分析と予測(市場参加者別、地域別、技術別、用途別、製品タイプ別)

Prof Research

Postmenopausal Osteoporosis Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

発刊日 2025/05/25

言語英語

体裁PDF/83ページ

ライセンス/価格83ページ

0000041666

Single
Site
Corporate

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

閉経後骨粗鬆症市場の概要

導入と市場概要

閉経後骨粗鬆症治療薬(ビスフォスフォネート、副甲状腺ホルモン療法、RANKリガンド阻害薬など)は、エストロゲン減少による女性の骨量減少を標的としており、世界中で数百万人が罹患し、年間900万件の骨折を引き起こしています。市場を牽引しているのは、高齢女性人口(2020年には60歳以上が10億人、2050年には21億人に達すると予測)で、高齢女性は骨折リスクが高いことが分かっています。骨粗鬆症による骨折、特に股関節骨折や脊椎骨折は、1年以内に死亡率20%、障害率50%につながり、医療費の増加につながっています。公衆衛生キャンペーン、骨密度スクリーニング、カルシウム欠乏症などの生活習慣要因が需要を押し上げています。世界の閉経後骨粗鬆症市場は、2025年には60億〜100億米ドル規模に達すると推定され、2030年まで年平均成長率3%〜7%で成長が見込まれています。

地域別市場動向

  • 北アメリカ:アメリカはDXAスクリーニングの普及を牽引し、カナダは骨折予防に重点を置いています。
  • ヨーロッパ:ドイツ、フランス、イギリスは、骨粗鬆症対策プログラムを強化し、成長を牽引しています。
  • アジア太平洋地域:中国とインドでは高齢化に伴い需要が高まっており、日本はビスフォスフォネート製剤に重点を置いています。
  • その他の地域:ブラジルは公衆衛生へのアクセスを拡大し、中東は高齢者ケアに取り組んでいます。

用途分析

  • 病院薬局:注射薬の普及が牽引役となり、3.5%〜7.5%の成長が見込まれます。トレンドは輸液センターに焦点が当てられています。
  • 小売薬局:経口剤の普及が牽引役となり、3.2%〜7.2%の成長が見込まれます。進歩は患者のコンプライアンス向上に重点を置きます。
  • オンライン薬局:デジタルアクセスの普及が牽引役となり、3.0%〜7.0%の成長が見込まれます。トレンドはサブスクリプションモデルに焦点を合わせています。

タイプ分析

  • ビスフォスフォネート:3.3〜7.3%の成長が見込まれ、骨折予防に有効とされています。トレンドはジェネリック医薬品に焦点を当てています。
  • 副甲状腺ホルモン療法:3.5〜7.5%の成長が見込まれ、高リスク患者に適しています。進歩は連日注射に重点を置いています。
  • カルシトニン:2.8〜6.8%の成長が見込まれ、鎮痛剤として使用されます。トレンドは点鼻スプレーに重点を置いています。
  • 選択的エストロゲン阻害薬モジュレーター(SERM):3.0〜7.0%の成長が見込まれ、中等症の症例をカバーします。トレンドは忍容性に重点を置いています。
  • ランクリガンド(RANKリガンド)阻害薬:3.7〜7.7%の成長が見込まれ、重症骨粗鬆症に有効とされています。トレンドは長期的な有効性に重点を置いています。
  • その他の製品:新規治療法をカバーし、2.7%〜6.7%の成長が見込まれます。開発においては、併用療法を優先します。

主要市場プレーヤー

  • Pfizer:骨の健康のためのビスフォスフォネート製剤を提供しています。
  • Merck:骨粗鬆症治療薬SERMを開発しています。
  • Amgen:RANKリガンド阻害剤を提供しています。
  • Eli Lilly:副甲状腺ホルモン療法に特化しています。
  • Novartis:手頃な価格のジェネリック医薬品に注力しています。

ポーターのファイブフォース分析

  • 新規参入の脅威:研究開発費の高さと規制上の障壁のため、低いです。
  • 代替品の脅威:中程度です。ライフスタイルの変化が競合しますが、重症患者には医薬品が主力となります。
  • 買い手の交渉力:ジェネリック医薬品の登場により価格競争が激化するため、高いです。
  • 供給者の交渉力:複数のAPIプロバイダーが存在するため、低いです。
  • 競合:中程度です。有効性とコストを巡る競争が激しいです。

市場機会と課題

  • 機会
    ➣ 年間900万件の骨粗鬆症性骨折への対応。
    ➣ 2050年までに21億人に達すると予測される高齢女性人口への支援。
    ➣ 高所得国で40%の普及率を誇るDXAスクリーニングの活用。
    ➣ 健康キャンペーンを活用し、診断率を向上。
    ➣ カルシウムとビタミンD欠乏症に伴う需要への対応。
    ➣ 骨折関連費用の削減(医療予算の1〜3%を占める)。
  • 課題
    ➣ RANK阻害薬などの生物学的製剤の高コスト。
    ➣ 長期治療における患者の服薬遵守の問題。
    ➣ 新薬の規制の遅れ。
    ➣ ジェネリック医薬品との競争による価格下落。
    ➣ 低所得地域におけるスクリーニングへのアクセスの制限。

レポート詳細

目次

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method

Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Postmenopausal Osteoporosis Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Historical and Forecast Postmenopausal Osteoporosis Market in North America (2020-2030)
8.1 Postmenopausal Osteoporosis Market Size
8.2 Postmenopausal Osteoporosis Market by End Use
8.3 Competition by Players/Suppliers
8.4 Postmenopausal Osteoporosis Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico

Chapter 9 Historical and Forecast Postmenopausal Osteoporosis Market in South America (2020-2030)
9.1 Postmenopausal Osteoporosis Market Size
9.2 Postmenopausal Osteoporosis Market by End Use
9.3 Competition by Players/Suppliers
9.4 Postmenopausal Osteoporosis Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru

Chapter 10 Historical and Forecast Postmenopausal Osteoporosis Market in Asia & Pacific (2020-2030)
10.1 Postmenopausal Osteoporosis Market Size
10.2 Postmenopausal Osteoporosis Market by End Use
10.3 Competition by Players/Suppliers
10.4 Postmenopausal Osteoporosis Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia

Chapter 11 Historical and Forecast Postmenopausal Osteoporosis Market in Europe (2020-2030)
11.1 Postmenopausal Osteoporosis Market Size
11.2 Postmenopausal Osteoporosis Market by End Use
11.3 Competition by Players/Suppliers
11.4 Postmenopausal Osteoporosis Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia

Chapter 12 Historical and Forecast Postmenopausal Osteoporosis Market in MEA (2020-2030)
12.1 Postmenopausal Osteoporosis Market Size
12.2 Postmenopausal Osteoporosis Market by End Use
12.3 Competition by Players/Suppliers
12.4 Postmenopausal Osteoporosis Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey

Chapter 13 Summary For Global Postmenopausal Osteoporosis Market (2020-2025)
13.1 Postmenopausal Osteoporosis Market Size
13.2 Postmenopausal Osteoporosis Market by End Use
13.3 Competition by Players/Suppliers
13.4 Postmenopausal Osteoporosis Market Size by Type

Chapter 14 Global Postmenopausal Osteoporosis Market Forecast (2025-2030)
14.1 Postmenopausal Osteoporosis Market Size Forecast
14.2 Postmenopausal Osteoporosis Application Forecast
14.3 Competition by Players/Suppliers
14.4 Postmenopausal Osteoporosis Type Forecast

Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Postmenopausal Osteoporosis Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Postmenopausal Osteoporosis Revenue, Gross Margin and Market Share (2020-2025)
15.2 Merck
15.2.1 Company Profile
15.2.2 Main Business and Postmenopausal Osteoporosis Information
15.2.3 SWOT Analysis of Merck
15.2.4 Merck Postmenopausal Osteoporosis Revenue, Gross Margin and Market Share (2020-2025)
15.3 Amgen
15.3.1 Company Profile
15.3.2 Main Business and Postmenopausal Osteoporosis Information
15.3.3 SWOT Analysis of Amgen
15.3.4 Amgen Postmenopausal Osteoporosis Revenue, Gross Margin and Market Share (2020-2025)
15.4 Eli Lilly
15.4.1 Company Profile
15.4.2 Main Business and Postmenopausal Osteoporosis Information
15.4.3 SWOT Analysis of Eli Lilly
15.4.4 Eli Lilly Postmenopausal Osteoporosis Revenue, Gross Margin and Market Share (2020-2025)
15.5 Novartis
15.5.1 Company Profile
15.5.2 Main Business and Postmenopausal Osteoporosis Information
15.5.3 SWOT Analysis of Novartis
15.5.4 Novartis Postmenopausal Osteoporosis Revenue, Gross Margin and Market Share (2020-2025)
15.6 Roche
15.6.1 Company Profile
15.6.2 Main Business and Postmenopausal Osteoporosis Information
15.6.3 SWOT Analysis of Roche
15.6.4 Roche Postmenopausal Osteoporosis Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list

Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Postmenopausal Osteoporosis Report
Table Data Sources of Postmenopausal Osteoporosis Report
Table Major Assumptions of Postmenopausal Osteoporosis Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Postmenopausal Osteoporosis Picture
Table Postmenopausal Osteoporosis Classification
Table Postmenopausal Osteoporosis Applications
Table Drivers of Postmenopausal Osteoporosis Market
Table Restraints of Postmenopausal Osteoporosis Market
Table Opportunities of Postmenopausal Osteoporosis Market
Table Threats of Postmenopausal Osteoporosis Market
Table Covid-19 Impact For Postmenopausal Osteoporosis Market
Table Raw Materials Suppliers
Table Different Production Methods of Postmenopausal Osteoporosis
Table Cost Structure Analysis of Postmenopausal Osteoporosis
Table Key End Users
Table Latest News of Postmenopausal Osteoporosis Market
Table Merger and Acquisition
Table Planned/Future Project of Postmenopausal Osteoporosis Market
Table Policy of Postmenopausal Osteoporosis Market
Table 2020-2030 North America Postmenopausal Osteoporosis Market Size
Figure 2020-2030 North America Postmenopausal Osteoporosis Market Size and CAGR
Table 2020-2030 North America Postmenopausal Osteoporosis Market Size by Application
Table 2020-2025 North America Postmenopausal Osteoporosis Key Players Revenue
Table 2020-2025 North America Postmenopausal Osteoporosis Key Players Market Share
Table 2020-2030 North America Postmenopausal Osteoporosis Market Size by Type
Table 2020-2030 United States Postmenopausal Osteoporosis Market Size
Table 2020-2030 Canada Postmenopausal Osteoporosis Market Size
Table 2020-2030 Mexico Postmenopausal Osteoporosis Market Size
Table 2020-2030 South America Postmenopausal Osteoporosis Market Size
Figure 2020-2030 South America Postmenopausal Osteoporosis Market Size and CAGR
Table 2020-2030 South America Postmenopausal Osteoporosis Market Size by Application
Table 2020-2025 South America Postmenopausal Osteoporosis Key Players Revenue
Table 2020-2025 South America Postmenopausal Osteoporosis Key Players Market Share
Table 2020-2030 South America Postmenopausal Osteoporosis Market Size by Type
Table 2020-2030 Brazil Postmenopausal Osteoporosis Market Size
Table 2020-2030 Argentina Postmenopausal Osteoporosis Market Size
Table 2020-2030 Chile Postmenopausal Osteoporosis Market Size
Table 2020-2030 Peru Postmenopausal Osteoporosis Market Size
Table 2020-2030 Asia & Pacific Postmenopausal Osteoporosis Market Size
Figure 2020-2030 Asia & Pacific Postmenopausal Osteoporosis Market Size and CAGR
Table 2020-2030 Asia & Pacific Postmenopausal Osteoporosis Market Size by Application
Table 2020-2025 Asia & Pacific Postmenopausal Osteoporosis Key Players Revenue
Table 2020-2025 Asia & Pacific Postmenopausal Osteoporosis Key Players Market Share
Table 2020-2030 Asia & Pacific Postmenopausal Osteoporosis Market Size by Type
Table 2020-2030 China Postmenopausal Osteoporosis Market Size
Table 2020-2030 India Postmenopausal Osteoporosis Market Size
Table 2020-2030 Japan Postmenopausal Osteoporosis Market Size
Table 2020-2030 South Korea Postmenopausal Osteoporosis Market Size
Table 2020-2030 Southeast Asia Postmenopausal Osteoporosis Market Size
Table 2020-2030 Australia Postmenopausal Osteoporosis Market Size
Table 2020-2030 Europe Postmenopausal Osteoporosis Market Size
Figure 2020-2030 Europe Postmenopausal Osteoporosis Market Size and CAGR
Table 2020-2030 Europe Postmenopausal Osteoporosis Market Size by Application
Table 2020-2025 Europe Postmenopausal Osteoporosis Key Players Revenue
Table 2020-2025 Europe Postmenopausal Osteoporosis Key Players Market Share
Table 2020-2030 Europe Postmenopausal Osteoporosis Market Size by Type
Table 2020-2030 Germany Postmenopausal Osteoporosis Market Size
Table 2020-2030 France Postmenopausal Osteoporosis Market Size
Table 2020-2030 United Kingdom Postmenopausal Osteoporosis Market Size
Table 2020-2030 Italy Postmenopausal Osteoporosis Market Size
Table 2020-2030 Spain Postmenopausal Osteoporosis Market Size
Table 2020-2030 Belgium Postmenopausal Osteoporosis Market Size
Table 2020-2030 Netherlands Postmenopausal Osteoporosis Market Size
Table 2020-2030 Austria Postmenopausal Osteoporosis Market Size
Table 2020-2030 Poland Postmenopausal Osteoporosis Market Size
Table 2020-2030 Russia Postmenopausal Osteoporosis Market Size
Table 2020-2030 MEA Postmenopausal Osteoporosis Market Size
Figure 2020-2030 MEA Postmenopausal Osteoporosis Market Size and CAGR
Table 2020-2030 MEA Postmenopausal Osteoporosis Market Size by Application
Table 2020-2025 MEA Postmenopausal Osteoporosis Key Players Revenue
Table 2020-2025 MEA Postmenopausal Osteoporosis Key Players Market Share
Table 2020-2030 MEA Postmenopausal Osteoporosis Market Size by Type
Table 2020-2030 Egypt Postmenopausal Osteoporosis Market Size
Table 2020-2030 Israel Postmenopausal Osteoporosis Market Size
Table 2020-2030 South Africa Postmenopausal Osteoporosis Market Size
Table 2020-2030 Gulf Cooperation Council Countries Postmenopausal Osteoporosis Market Size
Table 2020-2030 Turkey Postmenopausal Osteoporosis Market Size
Table 2020-2025 Global Postmenopausal Osteoporosis Market Size by Region
Table 2020-2025 Global Postmenopausal Osteoporosis Market Size Share by Region
Table 2020-2025 Global Postmenopausal Osteoporosis Market Size by Application
Table 2020-2025 Global Postmenopausal Osteoporosis Market Share by Application
Table 2020-2025 Global Postmenopausal Osteoporosis Key Vendors Revenue
Figure 2020-2025 Global Postmenopausal Osteoporosis Market Size and Growth Rate
Table 2020-2025 Global Postmenopausal Osteoporosis Key Vendors Market Share
Table 2020-2025 Global Postmenopausal Osteoporosis Market Size by Type
Table 2020-2025 Global Postmenopausal Osteoporosis Market Share by Type
Table 2025-2030 Global Postmenopausal Osteoporosis Market Size by Region
Table 2025-2030 Global Postmenopausal Osteoporosis Market Size Share by Region
Table 2025-2030 Global Postmenopausal Osteoporosis Market Size by Application
Table 2025-2030 Global Postmenopausal Osteoporosis Market Share by Application
Table 2025-2030 Global Postmenopausal Osteoporosis Key Vendors Revenue
Figure 2025-2030 Global Postmenopausal Osteoporosis Market Size and Growth Rate
Table 2025-2030 Global Postmenopausal Osteoporosis Key Vendors Market Share
Table 2025-2030 Global Postmenopausal Osteoporosis Market Size by Type
Table 2025-2030 Postmenopausal Osteoporosis Global Market Share by Type

この商品のレポートナンバー

0000041666

TOP